HIV/STD Risk and PrEP Implementation Messaging Among Gay, Bisexual, and Other Men Who Have Sex Wi… (NCT06183502) | Clinical Trial Compass
SuspendedNot Applicable
HIV/STD Risk and PrEP Implementation Messaging Among Gay, Bisexual, and Other Men Who Have Sex With Men
Stopped: Temporarily paused due to funding
United States1,275 participantsStarted 2024-06-29
Plain-language summary
The goal of this observational study is to learn about awareness around PrEP use and adherence, condom use, sexual risk-taking behavior, and substance-using behaviors in men having sex with men. The main objective is to study a prospective cohort of MSM in Atlanta, Chicago, and San Diego to understand men's strategies to prevent HIV/Sexually Transmissible Infections (STIs), including PrEP use and adherence, condom use, sexual risk-taking behavior, and substance-using behaviors
Participants will complete:
* Quantitative surveys quarterly
* HIV/ STI testing every 6 months
* Qualitative assessments: focus group discussions and in-depth interviews
Who can participate
Age range
18 Years
Sex
MALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Male at birth
* Self-identify as Cis-gender Male
* Ages 18 or older
* ≥1 Male anal sex partner in the 6 months before the baseline screener
* Live in or near Atlanta, Chicago, or San Diego
* Owns cell phone with data service
* Willing to download a health-related app to their cell phone as part of the research study
* Willing to participate in a 2-year cohort study with quarterly surveys and HIV and mailed STI self-testing
* Able to provide ≥ 2 means of contact
* Not currently enrolled in another HIV prevention clinical trial
* Not currently living with HIV
Exclusion Criteria:
* Female at birth
* Do not self-identify as Cis-gender Male
* Individuals \< 18 years of age
* HIV positive status
* No male anal sex partner in the 6 months before the baseline interview
* Does not own a mobile phone with data service
* Not willing to download a health-related app to their cell phone as part of the research study
* Live outside the metro Atlanta Metropolitan Statistical Area and/or planning to move from the Atlanta area in the next 2 years
* Currently enrolled in an HIV prevention or treatment clinical trial
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.